Home/Filings/4/0001209784-18-000012
4//SEC Filing

SMITH BRIAN 4

Accession 0001209784-18-000012

CIK 0001116463other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 5:40 PM ET

Size

13.4 KB

Accession

0001209784-18-000012

Insider Transaction Report

Form 4
Period: 2018-02-15
SMITH BRIAN
SVP, Molecular Solutions
Transactions
  • Exercise/Conversion

    Common stock

    2018-02-16$5.96/sh+10,000$59,59028,075 total
  • Sale

    Common stock

    2018-02-15$17.95/sh10,000$179,45018,075 total
  • Sale

    Common stock

    2018-02-16$18.00/sh10,000$180,01018,075 total
  • Exercise/Conversion

    Nonqualified stock options

    2018-02-1610,0000 total
    Exercise: $5.96Exp: 2023-12-20Common stock (10,000 underlying)
  • Exercise/Conversion

    Common stock

    2018-02-15$5.96/sh+10,000$59,59028,075 total
  • Exercise/Conversion

    Nonqualified stock options

    2018-02-1510,00010,000 total
    Exercise: $5.96Exp: 2023-12-20Common stock (10,000 underlying)
Footnotes (1)
  • [F1]Nonqualified stock options granted on December 20, 2013, vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.

Issuer

ORASURE TECHNOLOGIES INC

CIK 0001116463

Entity typeother

Related Parties

1
  • filerCIK 0001713865

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 5:40 PM ET
Size
13.4 KB